Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non-COVID-19 Sepsis but Carries a Moderately Increased Risk of Death

Hypertension. 2020 Jun;75(6):e15-e16. doi: 10.1161/HYPERTENSIONAHA.120.15178. Epub 2020 Apr 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensins
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Intensive Care Units
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2
  • Sepsis*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensins